This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Checkley, S.A. Articles by Arendt, J. Search for Related Content PubMed Articles by Checkley, S.A. Articles by Arendt, J. Social Bookmarking                         What's this?

Effects of a phosphodiesterase inhibitor (Rolipram) on the urinary excretion of 6-sulphatoxy melatonin in man

Maudsley Hospital, Denmark Hill, London, SE5

F. Winton

Maudsley Hospital, Denmark Hill, London, SE5

T. Corn

Maudsley Hospital, Denmark Hill, London, SE5

C. Franey

University of Surrey, Guildford, Surrey

J. Arendt

University of Surrey, Guildford, Surrey

The urinary excretion of 6-sulphatoxymelatonin (aMT6s) from 2400 to 0600 h was significantly increased following the treatment of ten normal volunteers with a phospho diesterase inhibitor (rolipram 1 mg 8 h for 24 h). The urinary excretion of the metabolite from 0600 to 1200 h was significantly reduced after treatment with rolipram.

Journal of Psychopharmacology, Vol. 1, No. 1, 20-22 (1987)
DOI: 10.1177/026988118700100105


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?